Connection

Abdullah Assiri to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications Abdullah Assiri has written about Drug Therapy, Combination.
Abdullah Assiri
Connection Strength
0.071
Drug Therapy, Combination
  1. Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome. N Engl J Med. 2020 10 22; 383(17):1645-1656.
    View in: PubMed
    Score: 0.020
  2. Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients. Saudi J Gastroenterol. 2019 Jan-Feb; 25(1):55-60.
    View in: PubMed
    Score: 0.018
  3. High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1-infected patients with severe chronic kidney disease. Liver Int. 2018 08; 38(8):1395-1401.
    View in: PubMed
    Score: 0.017
  4. Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-ß1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials. 2018 Jan 30; 19(1):81.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.